Prostate cancer: A hazard also to be considered in the ageing male patient with spinal cord injury

Spinal Cord

Volumn 36, Issue 5, 1998, Pages 299-302

  Wyndaele, J J ^a   Iwatsubo, E ^b   Perkash, I ^c   Stohrer M ^d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b SPINAL INJURIES CENTER   (Japan)

^c STANFORD UNIVERSITY   (United States)

^d Urology Department   (Germany)

Author keywords

Age; Catherterization; Prostate cancer; Spinal cord

Indexed keywords

ANDROGEN; ESTROGEN;

AGED; AGING; ARTICLE; BLADDER CATHETERIZATION; CASE REPORT; HUMAN; INDUSTRIALIZATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; SPINAL CORD INJURY;

EID: 0031944633     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100656     Document Type: Article

References (20)

1. Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull WHO 1984; 62: 163-182.
2. Denis LJ, Murphy GP, Schröder FH. Report of the Consensus Workshop on Screening and Global strategy for Prostate Cancer. Cancer 1995; 75: 1187-1207.
3. Muir CS, Nectoux J, Staszewski J. L'épidemiologie du cancer de la prostate. Répartition géographique et évolution dans le temps. In: Khoury S, Chatelain C (eds). Cancer de la prostate. FIIS: Malesherbes 1988, pp 128-137.
4. Merchant D. Etiology and prevention of prostatic cancer. Cancer chemo Rep 1975; 59: 65-66.
5. Bouffioux C. Le cancer de la prostate. Rapport à la Société Belge d'Urologie. Acta Urol Belg 1979; 47: 171-423.
6. Hackler RH. A 25 year prospective mortality study in the spinal cord injury patient. Comparison with the longterm living paraplegic. J Urol 1977; 117: 486-488.
7. Wein AJ, Barrett DM. Specific voiding dysfunctions associated with neurologic disease. In: Wein AJ, Barrett DM (eds). Voiding function and dysfunction. A logical and practical approach. Year Book Medical Publishers: Chicago 1988, pp 262-273.
8. Thomas DG. Spinal cord injury. In: Mundy AR, Stephenson TP, Wein AJ (eds). Urodynamics: principles, practice and application. Churchill-Livingstone: New York 1984; pp 260-272.
9. Gardner BP, Parsons KF. Upper urinary tract dilatation and stones. In: Parsons KF, Fitzpatrick JM (eds). Practical urology in spinal cord injury. Springer Verlag: London 1991; pp 43-56.
10. Gardner BP, Parsons KF, Machin DG, Galloway A, Krishnan KR. Urological management of spinal cord damaged patients. Paraplegia 1986; 24: 138-147.
11. Breithaupt DJ, Jousse AT, Wynne-Jones M. Late cause of death and life expectancy in paraplegia. Can Med Assoc J 1961; 85: 73-77.
12. Hartkopp A, Bronnum-Hansen H, Seidenschnur AM, Biering-Sorensen F. Survival and cause of death after traumatic spinal cord injury, a long-term epidemiological survey from Denmark. Spinal Cord 1997; 35: 76-85.
13. Wyndaele JJ, Maes D. Clean intermittent self-catheterization: a 12 year follow-up. J Urol 1990; 143: 906-908.
14. Sheldon CA, Williams RD, Fraley EE. Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 1980; 124: 626-631.
15. El-Masri WS, Fellows G. Bladder cancer after spinal cord injury. Paraplegia 1981; 19: 265-270.
16. Navon JD, Soliman H, Khonsari F, Ahlering T. Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder. J Urol 1997; 157: 2109-2111.
17. Stratton MD, McKirgan LW, Wade TP, Vernava AM, Virgo KS, Johnson FE, Longo WE. Colorectal cancer in patients with previous spinal cord injury. Dis Colon Rectum 1996; 39: 965-968.
18. Frisbie JH, Binard J. Low prevalence of prostatic cancer among myelopathy patients. J Am Paraplegia S 1994; 17: 148-149.
19. Renty P, D'Hauwers K, Van Camp C, Verheyden B, Gentens P, Wyndaele JJ. Value of transrectal prostatic enchography, prostate-specific antigen and rectal examination in the diagnosis of prostatic cancer. Relationship with the result of prostatic biopsies. Acta Urol Belg 1996; 64: 7-12.
20. Paul R, Breul J, Hartung R. Prostate-Specific Antigen density and age-specific Prostate-Specific Antigen values: the solution of prostate cancer screening. Eur Urol 1995; 27: 286-291.